stockrowXeris Biopharma Holdings, Inc.
XERS Healthcare Drug Manufacturers Specialty & Generic
Xeris Biopharma Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $291.8 million, up 43.7% from fiscal 2024.
- Revenue
- +44.2%
- EPS
- +1,479.0%
- Free cash flow
- +93.2%
- Total debt
- −13.6%
Quarter to September 2026, against a year earlier
Follow XERS
Alert me
Xeris Biopharma Holdings, Inc. (XERS) Total debt
Xeris Biopharma Holdings, Inc.'s total debt at the end of fiscal 2025 was $220.3M, down 5.07% from $232.1M in fiscal 2024. At the end of the quarter to 30 September 2026 it was $189.7M. Over the past ten years it has ranged from $31.9M (fiscal 2018) to $232.1M (fiscal 2024); the current reading is higher than 88% of that period. Xeris Biopharma Holdings, Inc. ranks 31st of 84 Drug Manufacturers Specialty & Generic companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $220.3M | (5.07%) |
| FY2024 | $232.1M | 21.57% |
| FY2023 | $190.9M | 1.21% |
| FY2022 | $188.7M | 114.22% |
| FY2021 | $88.1M | 1.20% |
| FY2020 | $87.0M | 49.25% |
| FY2019 | $58.3M | 82.83% |
| FY2018 | $31.9M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $189.7M | (24.89%) |
| Jun 2026 | $252.6M | 14.18% |
| Mar 2026 | $221.2M | 0.40% |
| Dec 2025 | $220.3M | 0.39% |
| 30 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| PRGO Perrigo Company plc compare | $3.3B |
| PBH Prestige Consumer Healthcare Inc. compare | $2.1B |
| ALVO Alvotech compare | $1.3B |
| BCRX BioCryst Pharmaceuticals, Inc. compare | $830.8M |
| TRLV Trulieve Cannabis Corp. compare | $345.0M |
| XERS Xeris Biopharma Holdings, Inc. | $189.7M |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | $94.5M |
| AMLX Amylyx Pharmaceuticals, Inc. compare | $1.4M |
| RGC Regencell Bioscience Holdings Limited compare | $463.7K |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on XERS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement